Loading…
Sera Prognostics, Inc. is projected to rise to $2.11 by 2027, a +2% move from its current price of $2.06. SERA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.99 | $2.06 | $2.14 | +0.01% |
| Jul 13 | $1.96 | $2.06 | $2.17 | +0.03% |
| Jul 14 | $1.93 | $2.06 | $2.20 | +0.04% |
| Jul 15 | $1.91 | $2.06 | $2.22 | +0.05% |
| Jul 16 | $1.90 | $2.06 | $2.24 | +0.07% |
| Jul 17 | $1.88 | $2.06 | $2.26 | +0.08% |
| Jul 18 | $1.87 | $2.06 | $2.27 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.87 | $2.06 | $2.27 | +0.09% |
| Week 2 | $1.80 | $2.06 | $2.37 | +0.18% |
| Week 3 | $1.75 | $2.07 | $2.44 | +0.27% |
| Week 4 | $1.70 | $2.07 | $2.51 | +0.37% |
| Week 5 | $1.66 | $2.07 | $2.57 | +0.46% |
| Week 6 | $1.63 | $2.07 | $2.63 | +0.55% |
| Week 7 | $1.60 | $2.07 | $2.68 | +0.64% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sera Prognostics, Inc. is a healthcare company focused on women's health. It discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States.
The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Sera Prognostics, Inc. (SERA) is currently trading at $2.03 per share. Its market capitalization is $79.49M and it ranks 4359 in market size. The current price sits within a forecast path that envisions modest moves in the near term and elevated expectations later on, with 2026 forecast average near $2.03 and bullish momentum developing into subsequent years that push the average toward $9.28 by 2050 and a 357% potential max ROI at that horizon.
A major floor 29.0% below — a decisive break under it would weaken the trend.
The nearest floor, 15.0% below — buyers have tended to step in here.
The nearest ceiling, 11.2% above — a clean break opens room to run.
A major ceiling 23.5% above — clearing it would confirm fresh momentum.
Key SERA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SERA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.04 | Buy | $2.01 | Buy |
| MA 10 | $1.96 | Buy | $1.98 | Buy |
| MA 20 | $1.90 | Buy | $1.96 | Buy |
| MA 50 | $1.93 | Buy | $1.98 | Buy |
| MA 100 | $2.02 | Buy | $2.14 | Sell |
| MA 200 | $2.60 | Sell | $2.50 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.83 | Neutral |
| Stoch RSI (14) | 50.39 | Neutral |
| CCI (20) | 48.61 | Neutral |
| Williams %R (14) | -41.38 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 7.07 | Buy |
| Bollinger %B (20,2) | 0.66 | Neutral |
| Stochastic %K (14) | 58.62 | Neutral |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | 0.05 | Buy |
| Ultimate (7,14,28) | 61.42 | Neutral |
| Momentum (10) | 0.17 | Buy |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 2.06 | Buy |
| ADX (14) | 13.32 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is bullish in tone. RSI(14) is 60, with the 50-day simple moving average at $1.94 and the 200-day simple moving average at $2.63. There is support at $1.74 and resistance at $2.29, framing a short-term trading range closer to the lower end of the current price.
The estimated 30-day trading range runs from $1.55 to $2.65, and annualized volatility sits at 80%, indicating sizable near-term price movement.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.59 | $2.06 | $2.48 | 0% | Neutral | |
| $1.62 | $2.11 | $2.92 | +2% | Neutral | |
| $1.79 | $2.41 | $3.51 | +17% | Neutral | |
| $2.15 | $3.00 | $4.53 | +46% | Bullish | |
| $2.09 | $2.99 | $4.66 | +45% | Bullish | |
| $1.99 | $2.93 | $4.68 | +42% | Bullish | |
| $2.08 | $3.14 | $5.14 | +52% | Bullish | |
| $1.93 | $2.99 | $5.01 | +45% | Bullish | |
| $2.05 | $3.24 | $5.53 | +57% | Bullish | |
| $2.51 | $4.07 | $7.07 | +98% | Bullish | |
| $2.66 | $4.76 | $8.92 | +131% | Bullish | |
| $4.65 | $10.02 | $20.92 | +387% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.59 | $2.06 | $2.44 | +0.00% |
| August 2026 | $1.69 | $2.02 | $2.48 | -2.12% |
| September 2026 | $1.73 | $2.08 | $2.60 | +3.39% |
| October 2026 | $1.69 | $2.05 | $2.59 | -1.66% |
| November 2026 | $1.58 | $1.93 | $2.46 | -5.89% |
| December 2026 | $1.56 | $1.92 | $2.48 | -0.35% |
Click any year to see its month-by-month SERA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Sera Prognostics, Inc.'s 2026 outlook centres on $2.06, within a $1.59 to $2.48 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SERA could reach as high as $2.92, with a base case around $2.11 and support toward $1.62 — roughly +2% from $2.06. A consolidation phase looks the most probable path here.
Expect SERA to range from $1.79 to $3.51 through 2028. The $2.41 average target implies a +17% move from current prices. That is up +15% on the projected 2027 average. Price action looks broadly range-bound.
The SERA price prediction for 2029 points to an average of $3.00 (low $2.15, high $4.53) — a potential gain of +46% on today's $2.06. Buyers look set to stay in control over this stretch.
In 2030, SERA is projected to trade between $2.09 and $4.66, averaging $2.99 — a potential gain of +45% from today's $2.06. That is 0% versus the projected 2029 average. Momentum favours further upside here.
Sera Prognostics, Inc.'s 2031 outlook centres on $2.93, within a $1.99 to $4.68 range. That is -2% versus the projected 2030 average. That marks a +42% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SERA could reach as high as $5.14, with a base case around $3.14 and support toward $2.08 — roughly +52% from $2.06. Momentum favours further upside here.
Expect SERA to range from $1.93 to $5.01 through 2033. The $2.99 average target implies a +45% move from current prices. That is -5% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The SERA price prediction for 2034 points to an average of $3.24 (low $2.05, high $5.53) — a potential gain of +57% on today's $2.06. Momentum favours further upside here.
In 2035, SERA is projected to trade between $2.51 and $7.07, averaging $4.07 — a potential gain of +98% from today's $2.06. That is up +26% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Sera Prognostics, Inc.'s 2040 outlook centres on $4.76, within a $2.66 to $8.92 range. That is up +17% on the projected 2035 average. That marks a +131% change versus current levels. Momentum favours further upside here.
By 2050, SERA could reach as high as $20.92, with a base case around $10.02 and support toward $4.65 — roughly +387% from $2.06. Buyers look set to stay in control over this stretch.
Investing $1,000 in SERA today (≈ 485.436893 SERA) could be worth
$4,865.02
+$3,865.02 (+387%) by 2050 · US Dollar
Based on the average projected SERA price of $10.02 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SERAwould be worth at today's price.
$1,000 invested in SERA on Jul 10, 2025 (≈ 362.318842 SERA) would be worth
$746.38
-$253.62 (-25.4%) today · 0.75× · US Dollar
Based on a SERA entry price of $2.76 vs. today's $2.06.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2 | $1,030 | +3.0% |
| 1 month ago | $2 | $1,030 | +3.0% |
| 3 months ago | $1.97 | $1,045.69 | +4.6% |
| 6 months ago | $3.6 | $573.02 | -42.7% |
| 1 year ago | $2.76 | $746.38 | -25.4% |
| All time (5.0y) ago | $11.9 | $173.11 | -82.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SERA forecast.
Our base-case forecast reaches $4.10 around 2040.
Implied market cap at $4.10: $156.58M
The multi-year forecast shows a generally bullish trajectory after a neutral start. By 2030, the average forecast price is $2.86 with a min of $1.94 and a max of $4.58, yielding a 41% ROI and a bullish outlook. The 2040 forecast projects an average of $4.32 with a max of $8.42 and an 112.8% ROI, remaining bullish.
By 2050, the average is $9.28 with a max of $20.27 and a 357% ROI, with the sentiment staying bullish. These projections imply rising prices over time, though they are estimates and not guarantees; outcomes depend on market conditions and other factors that can change.
Tap a question to reveal the answer.
2030 forecast: min $1.94, avg $2.86, max $4.58; ROI 41%; sentiment BULLISH.
Forecasts turn bullish from 2029 onward, with 2030 avg $2.86 and ROI 41%, and by 2050 avg $9.28 with ROI 357%; 2026-2028 are neutral.
Yes. The 2032 forecast max is $5.08 and the 2034 forecast max is $5.18.
The max forecast price by 2050 is $20.27, with an average of $9.28 and ROI 357%.
Current price is $2.03 and market cap is $79.49M.
Sera Prognostics, Inc. Community Discussion
0Share your Sera Prognostics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.